Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,276–5,300 of 7,816 matching trials · page 212 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Control and Intervention Programme on Alzheimer's Disease Risk Factors NCT02772523 Lifestyle recommendations Runs in: Spain · 1 site |
NA other |
COMPLETED | 409 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation OTHER |
2020-07-21 |
|
Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD) NCT03173846 Runs in: Spain · 1 site |
NA other |
COMPLETED | 90 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation OTHER |
2020-07-21 |
|
Caring for Persons With Dementia and Their Caregivers in the Community NCT04479033 Multidisciplinary collaborative model of community care management Runs in: Singapore · 1 site |
NA other |
UNKNOWN | 300 | Duke-NUS Graduate Medical School OTHER |
2020-07-21 |
|
Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI) NCT02819700 prevalence of behavioural dysexecutive syndrome Runs in: France · 2 sites |
NA other |
COMPLETED | 49 | Centre Hospitalier Universitaire, Amiens OTHER |
2020-07-20 |
|
Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 NCT00476671 lumbar puncture, MRI, MRS Runs in: Thailand · 1 site |
NA other |
COMPLETED | 100 | The HIV Netherlands Australia Thailand Research Collaboration OTHER |
2020-07-17 |
|
Deep Brain Stimulation for Alzheimer's Disease NCT03959124 Deep brain stimulation; Best medical treatment for Alzheimer's disease Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 30 | Buddhist Tzu Chi General Hospital OTHER |
2020-07-17 |
|
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). NCT02670083 Crenezumab; Placebo Runs in: Australia; Austria; Belgium; Bulgaria; Canada; Costa Rica... · 196 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 813 | Hoffmann-La Roche INDUSTRY |
2020-07-16 |
|
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) NCT03114657 Crenezumab; Placebo Runs in: Argentina; Australia; Belgium; Brazil; Canada; China; Den... · 211 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 806 | Hoffmann-La Roche INDUSTRY |
2020-07-16 |
|
A Goal-setting With Mentoring Lifestyle Modification Intervention to Reduce Risk of Dementia in Later Life NCT03900156 goal-setting Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 94 | Tzu-Ting Huang OTHER |
2020-07-15 |
|
Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment NCT01464515 H-Coil Deep TMS; SHAM Coil TMS Runs in: Israel · 1 site |
PHASE1 other |
UNKNOWN | 30 | Brainsway INDUSTRY |
2020-07-14 |
|
Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations NCT02578303 Vascular flow measurement by PC-MRI Runs in: France · 1 site |
NA other |
UNKNOWN | 139 | Central Hospital Saint Quentin OTHER_GOV |
2020-07-14 |
|
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children NCT02720705 Dexmedetomidine; saline Runs in: Egypt · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 90 | Assiut University OTHER |
2020-07-14 |
|
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease NCT03542474 High Intensity Endurance Exercise Runs in: United States · 1 site |
NA other |
COMPLETED | 8 | Northwestern University OTHER |
2020-07-14 |
|
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly NCT01951118 Donepezil Runs in: United States · 1 site |
PHASE4 symptomatic-cholinergic |
COMPLETED | 121 | New York State Psychiatric Institute OTHER |
2020-07-13 |
|
Brain Sleep Deprivation MRI Effects (BEDTIME) NCT02741505 Actigraph Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | NYU Langone Health OTHER |
2020-07-13 |
|
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease NCT03491150 Crenezumab Runs in: Australia; Canada; Finland; France; Germany; Hong Kong; I... · 66 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 149 | Hoffmann-La Roche INDUSTRY |
2020-07-13 |
|
Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) NCT03891277 Ferrous succinate Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 1,006 | Beijing Tiantan Hospital OTHER |
2020-07-13 |
|
A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis NCT02292186 Revusiran (ALN-TTRSC) Runs in: Canada; United Kingdom; United States · 5 sites |
PHASE2 other |
COMPLETED | 25 | Alnylam Pharmaceuticals INDUSTRY |
2020-07-09 |
|
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients NCT03184467 Normal Saline 0.9%; GV1001 0.56 mg; GV1001 1.12 mg Runs in: South Korea · 1 site |
PHASE2 other |
COMPLETED | 96 | GemVax & Kael INDUSTRY |
2020-07-09 |
|
Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease NCT03384043 Smartphone Personal Assistant; Implementation Intention Runs in: United States · 1 site |
NA other |
COMPLETED | 52 | Baylor University OTHER |
2020-07-08 |
|
Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production NCT03971123 Tricaprilin; Tricaprilin; Placebo; Tricaprilin Runs in: Australia · 1 site |
PHASE1 other |
COMPLETED | 32 | Cerecin INDUSTRY |
2020-07-08 |
|
Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production NCT04268953 Tricaprilin Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | Cerecin INDUSTRY |
2020-07-08 |
|
Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease NCT00277810 lecozotan SR (SRA-333) Runs in: Argentina; Australia; Canada; Finland; France; Italy; Pol... · 83 sites |
PHASE2|PHASE3 other |
COMPLETED | 250 | Pfizer INDUSTRY |
2020-07-07 |
|
Cognitive Decline in Non-demented PD NCT01340885 Strattera; Exelon; Placebo Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 9 | Oregon Health and Science University OTHER |
2020-07-07 |
|
RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play NCT03270813 Relaxation training plus RAGE-Control; Relaxation training plus Sha... Runs in: United States · 1 site |
NA other |
UNKNOWN | 40 | Massachusetts General Hospital OTHER |
2020-07-07 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial